Insulin-producing organoids engineered ...
Document type :
Article dans une revue scientifique: Article original
PMID :
Permalink :
Title :
Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes.
Author(s) :
Lebreton, Fanny [Auteur]
Lavallard, Vanessa [Auteur]
Bellofatto, Kevin [Auteur]
Bonnet, Romain [Auteur]
Wassmer, Charles H. [Auteur]
Perez, Lisa [Auteur]
Kalandadze, Vakhtang [Auteur]
Follenzi, Antonia [Auteur]
Boulvain, Michel [Auteur]
Pattou Kerr-Conte, Julie [Auteur]
Recherche translationnelle sur le diabète (RTD) - U1190
Goodman, David J. [Auteur]
Bosco, Domenico [Auteur]
Bernez, Thierry [Auteur]
Berishvili, Ekaterine [Auteur]
Lavallard, Vanessa [Auteur]
Bellofatto, Kevin [Auteur]
Bonnet, Romain [Auteur]
Wassmer, Charles H. [Auteur]
Perez, Lisa [Auteur]
Kalandadze, Vakhtang [Auteur]
Follenzi, Antonia [Auteur]
Boulvain, Michel [Auteur]
Pattou Kerr-Conte, Julie [Auteur]

Recherche translationnelle sur le diabète (RTD) - U1190
Goodman, David J. [Auteur]
Bosco, Domenico [Auteur]
Bernez, Thierry [Auteur]
Berishvili, Ekaterine [Auteur]
Journal title :
Nature Communications
Abbreviated title :
Nat Commun
Volume number :
10
Pages :
4491
Publication date :
2019-10-03
ISSN :
2041-1723
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Maintaining long-term euglycemia after intraportal islet transplantation is hampered by the considerable islet loss in the peri-transplant period attributed to inflammation, ischemia and poor angiogenesis. Here, we show ...
Show more >Maintaining long-term euglycemia after intraportal islet transplantation is hampered by the considerable islet loss in the peri-transplant period attributed to inflammation, ischemia and poor angiogenesis. Here, we show that viable and functional islet organoids can be successfully generated from dissociated islet cells (ICs) and human amniotic epithelial cells (hAECs). Incorporation of hAECs into islet organoids markedly enhances engraftment, viability and graft function in a mouse type 1 diabetes model. Our results demonstrate that the integration of hAECs into islet cell organoids has great potential in the development of cell-based therapies for type 1 diabetes. Engineering of functional mini-organs using this strategy will allow the exploration of more favorable implantation sites, and can be expanded to unlimited (stem-cell-derived or xenogeneic) sources of insulin-producing cells.Show less >
Show more >Maintaining long-term euglycemia after intraportal islet transplantation is hampered by the considerable islet loss in the peri-transplant period attributed to inflammation, ischemia and poor angiogenesis. Here, we show that viable and functional islet organoids can be successfully generated from dissociated islet cells (ICs) and human amniotic epithelial cells (hAECs). Incorporation of hAECs into islet organoids markedly enhances engraftment, viability and graft function in a mouse type 1 diabetes model. Our results demonstrate that the integration of hAECs into islet cell organoids has great potential in the development of cell-based therapies for type 1 diabetes. Engineering of functional mini-organs using this strategy will allow the exploration of more favorable implantation sites, and can be expanded to unlimited (stem-cell-derived or xenogeneic) sources of insulin-producing cells.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Submission date :
2024-01-19T23:42:13Z
2024-09-25T12:20:12Z
2024-09-25T12:20:12Z
Files
- s41467-019-12472-3.pdf
- Non spécifié
- Open access
- Access the document